Misbah Tahir
Vermögen: - $ am 30.06.2026
Vermögen: - $ am 30.06.2026
Misbah Tahir is currently Chief Financial & Accounting Officer at Maze Therapeutics, Inc. since 2026.
Formerly, served as Chief Financial Officer at IGM Biosciences, Inc. from 2019 to 2025.
Previously, was Vice President & Head-Finance at Dermira, Inc. from 2014 to 2018.
Education includes undergraduate studies at the University of Pennsylvania and an MBA from Stephen M.
Ross School of Business.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
Maze Therapeutics, Inc.
Maze Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops medicine for cardiovascular, renal and metabolic diseases -.--% | 31.03.2026 | 0 ( -.--% ) | - $ | 30.06.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
Maze Therapeutics, Inc.
Maze Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops medicine for cardiovascular, renal and metabolic diseases | Finanzdirektor/CFO | 02.09.2025 |
| Unternehmen | Position | Ende |
|---|---|---|
| IGM BIOSCIENCES, INC. | Finanzdirektor/CFO | 01.08.2025 |
| DERMIRA, INC. | Corporate Officer/Principal | 01.12.2018 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 5 |
|---|---|
University of Pennsylvania
University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Stephen M. Ross School of Business
Stephen M. Ross School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Dermira, Inc.
Dermira, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products to patients living with chronic skin conditions | Health Technology |
IGM Biosciences, Inc.
IGM Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops engineered IgM antibodies for the treatment of cancer patients | Health Technology |
Maze Therapeutics, Inc.
Maze Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops medicine for cardiovascular, renal and metabolic diseases | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen